Sexual Dysfunction

Latest News

Phase 2 study launches of bremelanotide plus a PDE5 inhibitor for erectile dysfunction
Phase 2 study launches of bremelanotide plus a PDE5 inhibitor for erectile dysfunction

June 20th 2024

A novel co-formulation of bremelanotide and a PDE5 inhibitor allows the treatment to be administered to patients via a single injection.

Man talking with a doctor | Image Credit: © DragonImages - stock.adobe.com
Agreement reached to expand distribution of avanafil for ED

April 26th 2024

Man talking with a doctor, who is taking notes on a clipboard | Image Credit: © Khunatorn - stock.adobe.com
Fertility preservation in patients with testicular cancer

March 8th 2024

Study of avanafil for OTC use in erectile dysfunction progresses
Study of avanafil for OTC use in erectile dysfunction progresses

January 19th 2024

Cleveland Clinic trial compares shockwave vs radial wave therapy for ED in prostate cancer survivors
Cleveland Clinic trial compares shockwave vs radial wave therapy for ED in prostate cancer survivors

December 14th 2023

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.